Primatene inhaler moves closer to US return

8 January 2014 - Deborah Wilkes

Archived

Armstrong Pharmaceuticals could soon have an OTC asthma inhaler back on the market in the US under its established Primatene brand name.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: